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Summary 
Extracellular proteins are not generally presented on 
class I MHC molecules in vitro, yet many studies show 
that a pathway exists in vivo for the presentation of 
extracellular material on class I molecules to prime 
CDS+ T cell responses. Here, we provide morphologi- 
cal evidence that proteins taken up by macropino- 
cytosis can gain access to the cytosol and therefore 
into the conventional class I MHC pathway. Class I pre- 
sentation of soluble ovalbumin by mouse bone marrow 
macrophages was dramatically enhanced by MCSF or 
phorbol ester and blocked by amiloride, which stimu- 
late and inhibit membrane ruffling and macropino- 
cytosis, respectively. Brefeldln A, gelonin, and a pep 
tide aldehyde inhibitor of proteasomal processing 
each blocked presentation of macropinocytosed anti- 
gen, demonstrating that unusual access to the con- 
ventional class I MHC pathway was occurring. This 
novel cell type-specific endocytic pathway may facili- 
tate presentation of exogenous material on class I MHC 
molecules, allowing induction of CDS+ T cell responses 
to soluble protelns, tumor cell fragments, and some 
pathogens. 
introduction 
The conventional view of antigen presentation to T cells 
is that endogenous proteins are presented on class I major 
histocompatibility complex (MHC) molecules and exoge- 
nous proteins on class II MHC molecules (Morrison et al., 
1986; Bevan, 1987; Townsend and Bodmer, 1989; Ger- 
main and Marguiles, 1993). However, an increasing num- 
ber of reports demonstrate that this division is not absolute 
and that a significant level of cross-over can occur, such 
that peptides from endogenous cytosolic proteins may ap- 
pear on class II MHC molecules (Jaraquemada et al., 
1990; Dodi et al., 1994) and peptides from exogenous pro- 
teins on class I MHC molecules. CDS+ T cell responses 
can be elicited in vivo in the absence of de novo antigen 
synthesis within host antigen-presenting cells (APCs). 
These responses have been observed following immuni- 
zation with purified proteins (Wraith et al., 1967; Staerz 
et al.,1987; Bachmann et al., 1994; Schirmbeck et al., 
1995; Blum-Tirouvanziam et al., 1994; Ke et al., 1995) and 
in cross-priming experiments where CD8 T cell responses 
to antigens carried uniquely by immunizing donor cells are 
restricted to MHC molecules expressed only on recipient 
Cells (Bevan, 1976; Gooding and Edwards, 1980; Fink et 
al., 1983; Huang et al., 1994.). 
Based on these findings, it has been suggested that a 
pathway must exist for the processing and presentation 
of exogenous material on class I MHC molecules (Bevan, 
1987; Townsend and Bodmer, 1989). However, it has been 
difficult to analyze this unusual mode of class I peptide 
loading in vitro where exogenous proteins are usually pre- 
sented on class II MHC and not on class I MHC molecules 
(Morrison et al., 1986). Rock and colleagues (Rock et al., 
1990) have demonstrated class I MHC-restricted presen- 
tation in vitro of exogenous soluble antigen and much 
more efficient presentation of antigen conjugated to latex 
beads(Kovacsovics-Bankowski et al., 1993). However, the 
mechanistic basis for class I MHC presentation of phago- 
cytosed particulate antigens is somewhat unclear, since 
different studies, both using latex bead-associated anti- 
gen, report a brefeldin A-insensitive pathway in one case 
(Harding and Song, 1994) but brefeldin A-sensitive presen- 
tation in another (Kovacsovics-Bankowski and Rock, 
1995). Brefeldin-insensitive presentation of bacterial anti- 
gen (Pfeifer et al., 1993) and heat-inactivated virus prepa- 
rations in some cell types (Liu et al., 1995) have also been 
described. Thus, the question of how exogenous physio- 
logical antigens, both particulate and nonparticulate, 
might accesstheclass I MHC pathway following endocyto- 
sis is not clearly resolved. 
Endocytic pathways distinct from the clathrin-mediated 
route have now been described in animal cells (reviewed 
by van Deurs et al., 1990; Watts and Marsh, 1992). Macro- 
pinocytosis is a cell type-specific endocytic pathway asso- 
ciated with plasma membrane ruffling activity (Swanson 
and Watts, 1995). It can be induced by growth factors, 
phorbol esters (West et al., 1989; Swanson, 1969; Racoo- 
sin and Swanson, 1993; Hewlett et al., 1994), or activated 
forms of the small GTP binding protein rat (Ridley et al., 
1992) and appears to operate constitutively in cultured 
human dendritic cells (Sallusto et al., 1995). Macropino- 
cytosis, but not other endocytic pathways, is blocked by 
the Na+/H+ channel inhibitor amiloride (West et al., 1989) 
or its analogs (Hewlett, 1995). Macropinosomes are het- 
erogeneous in size (Swanson, 1989; Hewlett et al., 1994) 
and interact with lysosomes in macrophages (Racoosin 
and Swanson, 1993), but in human A431 epithelial cells 
they comprise a distinct endosome population refractory 
to fusion with other endosomes (Hewlett et al., 1994). We 
made the surprising observation that extracellular tracers 
taken up during ruffling and macropinocytosis in human 
A431 cells were later found in the cytosol, which led us 
to test the hypothesis that this endocytic pathway may 
provide a mechanism for presentation of exogenous anti- 
gen on class I MHC molecules. 
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Figure 1. Release of Solute Markers into the Cytosol following Induction of Macropinocytosis 
(a) A431 cells were incubated with HRP in the presence (A, C, D) or absence (B) of EGF for 10 min, then fixed and peroxidase cytochemistry 
performed immediately (A) or following a 90 min chase (B, C. D). Macropinosomes, heterogeneous in size. can be seen close to the ruffling margins 
of a group of cells (A). 
(b) Quantitation. after different chase times of cells showing cytosolic HRP reaction product. A cell was scored if it excluded trypan blue and the 
brown HRP precipitate was excluded from the nuclear region. In all cases, a minimum of 500 cells were counted. Scale bars, (a), 20 nm (A, 0); 
50 pm (B. C). A431 cells were grown on sterile 13 mm coverslips, then pulsed with 10 mg/ml HRP in the presence or absence of 300 rig/ml EGF 
as described previously (West et al., 1989; Hewlett et al., 1994) and, where indicated, chased at 37T. After fixation, HRP cytochemistry was 
performed with diaminobenzidine (0.5 mg/ml) and H& (0.01%). 
Results 
Detection of Macropinocytosed Markers 
in the Cytosol 
In human A431 cells stimulated with epidermal growth 
factor (EGF) in the presence of horseradish peroxidase 
(HRP), macropinosomes of various sizes can be observed 
in the cytosol, frequently in close proximity to the cell mar- 
gins where ruffling activity is maximal (Figure la, A) (West 
et al., 1989; Hewlett et al., 1994). Although most macropi- 
nocytosed tracer is recycled out of these cells during a 
chase period at 37% we detected HRP activity in the 
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cytosol in a proportion of cells (Figure la, C and D). These 
cells were viable since HRP was excluded from the nu- 
cleus (Figure 1, C and D) and the cells did not take up 
trypan blue (data not shown). Cytosolic HRP was seen 
only in EGF-stimulated cells (Figure la, compare B and 
C), which also contained intact macropinosomes and were 
therefore alive during the HRP pulse. Most importantly, 
HRPonlyappearedin thecytosolfollowingachaseperiod, 
i.e., after removal of exogenous HRP, demonstrating a 
time-dependent release into the cytosol. Approximately 
9% of cells were visibly loaded with cytosolic HRP follow- 
ing a 90 min chase period (Figure la, C and D; Figure 1 b). 
This surprising observation raised the possibility that 
macropinocytosis might provide a pathway for the presen- 
tation of exogenous antigens on class I MHC molecules 
via the cytosol. We tested this hypothesis using mouse 
bone marrow macrophages (BMM) in which macropino- 
cytosis has been well characterized (Swanson, 1989; Ra- 
coosin and Swanson, 1993) and which constitute a physio- 
logically relevant cell type in the context of antigen 
presentation and CTL priming. Mouse BMM were stimu- 
lated with either MCSF or phorbol ester in the presence 
of fluorescein isothiocyanate (FITC)-dextran. HRP is less 
suitable as a fluid phase endocytic marker in BMM since 
it stimulates its own uptake (Swanson et al., 1985). As in 
A431 cells, macropinosomes in BMM were heterogeneous 
in size (Figures 2A and 28) and their formation could be 
blocked by amiloride or its analogs(data not shown; Figure 
3c; see below). In addition, we observed FITC-dextran 
release into the cytosol of some living cells (see Figures 
2C and 2D). However, since cytosolic release was again 
seen only in a minority of cells it seemed that although 
BMM would not be efficiently lysed in a CTL assay follow- 
ing induction of this pathway they might nonetheless be 
able to trigger T cell activation. We therefore utilized the 
Lac Z-inducible T cell hybridoma 832 (Karttunen et al., 
1992), specific for the ovalbumin epitope 257-284 pre- 
sented on the murine class I MHC molecule H-2@ (Moore 
et al., 1988). 832 activation is detectable when the fre- 
quency of presenting cells is as low as 0.1 %-0.01% (Kart- 
tunen et al., 1992; Sanderson and Shastri, 1994). 
Macropinocytosed Antigen Is Loaded onto 
Class I MHC Molecules 
BMM were pulsed with soluble ovalbumin for 10 min under 
conditions that stimulate or inhibit macropinocytosis. The 
cells were then incubated without ovalbumin for different 
times, fixed, and overlaid with 832 T cells. Presentation 
of the ovalbumin257-~ epitope was assessed by scoring 
the number of activated (blue) 832 T cells. Exposure of 
BMM to ovalbumin in the presence of phorbol myristate 
acetate (PMA) gave a time-dependent increase in trig- 
gering of the 832 T cells (Figure 3a). Amiloride added 
during the antigen pulse markedly reduced subsequent T 
cell triggering (Figure 3b). Thus, presentation of exoge- 
nous ovalbumin was enhanced or blocked, respectively, 
by stimulators and inhibitors of macropinocytosis. 
To eliminate the possibility that PMA and amiloride were 
modulating presentation of ovalbumin via generalized ef- 
fects, for example, on the level of class I MHC or adhesion 
molecules, we compared the effect of PMA and the more 
potent amiloride analog, dimethyl amiloride(DMA) on oval- 
bumin presentation versus presentation of a synthetic 
ovalbumin257-2s4 peptide (SIINFEKL) recognized by 832 
cells. The DMA concentrations that blocked PMA-stimu- 
lated macropinocytosis of FITC-dextran (Figure 3d) also 
inhibited PMA-stimulated and constitutive presentation of 
intact ovalbumin (Figure 3c). In contrast, even high DMA 
concentrations had no detectable effect on peptide pre- 
sentation. Moreover, in contrast with ovalbumin presenta- 
tion, peptide presentation was, if anything, slightly inhib- 
ited by PMA (Figure 38). The inhibitory effect of DMA on 
class I presentation correlates strictly with its parallel ef- 
fects on macropinocytosis, since it inhibited ovalbumin 
presentation only when it was included during the antigen 
pulse and not when it was present for the same length of 
time either before or after pulsing (Table 1). BMM exhibit 
a significant level of constitutive ruffling and macropino- 
cytosis, which presumably accounts for the DMA-inhibit- 
able presentation of ovalbumin seen in the absence of 
PMA (e.g., Figure 3c). Thus, PMA and DMA modulate anti- 
gen presentation via their effects on ruffling and macropi- 
nocytosis and not by modulating cell surface expression 
of class I MHC or accessory molecules. 
Unconventional Access to the Conventional 
Class I MHC Pathway 
Release of exogenous markers into the cytosol following 
macropinocytosis seemed likely to account for the in- 
creased expression of exogenous ovalbumin on class I 
MHC molecules. However, other studies have suggested 
that exogenous antigens may be loaded onto mature class 
I MHC molecules (Pfeifer et al., 1993; Harding and Song, 
1994; Liu el al., 1995). To assess whether newly synthe- 
sized class I molecules and a functional secretory pathway 
are required for presentation of macropinocytosed oval- 
bumin, we tested the effects of gelonin, a protein synthesis 
inhibitor (Stirpe et al.,l980), and brefeldin A, which blocks 
secretory protein traffic and class I MHC antigen presenta- 
tion (Nuchtern et al., 1989; Yewdell and Bennink, 1989). 
Gelonin added during the antigen pulse inhibited oval- 
bumin presentation (Figure 4a) but not presentation of the 
synthetic peptide ovalbumin257-2&( (data not shown), indi- 
cating that newly synthesized class I MHC molecules are 
required for presentation of macropinocytosed ovalbumin. 
Since gelonin is impermeant to intact cells (Stirpe el al., 
1980; Rock et al., 1993), these data provide independent 
evidence that macropinocytosis provides access of solu- 
ble proteins to the cytosol. When ovalbumin-pulsed macro- 
phages were subsequently incubated with brefeldin A, trig- 
gering of 832 cells was strongly inhibited (Figure 4b). 
However, following a period of recovery in the absence 
of brefeldin A and without further exposure to ovalbumin, 
the macrophages became competent to activate the 832 
cells (Figure 4b), demonstrating that the effect of brefeldin 
A is reversible and that presentation of macropinocytosed 
ovalbumin depends on a functional secretory pathway. 
We next assessed whether, priorto class I MHC loading, 
Figure 2. BMM Pulsed with FITC-Dextran in the Presence of MCSF 
Phase contrast (A, C) and confocal fluorescence (FITC) fields of the same cells showing macropinosomes (B, D) and, less frequently, cells showi 
cytosolic staining (C, 0). Intact macropinoeomes are also observed within cells showing cytosolic fluorescence (arrow in C and 0). 
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Figure 3. Effects of PMA and Amiloride on 
Macropinocytosis and Class I Presentation of 
Exogenous Antigens 
BMM untreated (open square) or treated 
(closed square) with 30 rig/ml PMA to induce 
macropinocytosis 45 min prior to pulsing with 
either ovalbumin (a, b, c), ovalbumin 257-284 
(e). or FlTC-dextran (d). Time-dependent pre- 
sentation of native ovalbumin by ovalbumin- 
pulsed cells (a). Effect on ovalbumin (b, c) or 
ovalbumin 257-284 (e) presentation by amilor- 
ide (b) or dimethyl amiloride (c, e). Effect of 
dimethyl amiloride on FITC-dextran uptake 
into BMM (d). 
BMM were replated at 3 x 106 cells/well in 24- 
well plates 8-18 hr and PMA added where indi- 
cated (closed square) 45 min prior to pulsing 
with batch-tested (see Experimental Proce- 
dures) ovalbumin (10 mglml) or ovalbumin~,~ 
(0.1 pM) or FITC-dextran (10 mg/ml). For pre- 
sentation studies, BMM were washed exten- 
sively with PBWBSA following ovalbumin puls- 
ing, then incubated for 2 hr at 37W. 832 cells 
were overlaid at a density of 4 x 106 cells/well 
and incubated overnight at 37OC, then har- 
vested by vigorous pipetting. 8galactosidase activity was assayed using X-Gal as described (Sanderson and Shastri, 1994; Karttunnen et al., 
1992). In (a), cells were fixed with 1% paraformaldehyde for 30 min and quenched with 0.2 M glycine in PBS, washed, and then incubated with 
832 indicator cells. The percentage of activated blue 832 cells was determined by cell counting. At least 1500-3000 total cells were counted. 
Experiments were performed in triplicate and the results presented as means f SD. In (d), PMA-treated cells were washed extensively following 
exposure to FITC-dextran (5 mglml), then lysed in 0.2% Triton-X 100 and microfuged to remove aggregates. FITC content was measured in a 
Perkin-Elmer fluorimeter (excitation, 490 nm; emission, 520 nm; 2.5nm, bandpass). Controls without PMA or amiloride received equivalent amounts 
of DMSO carrier. 
processing of ovalbumin occurred within macropinosomal 
compartments or in the cytosol via the action of the protea- 
some complex. Presentation of exogenous ovalbumin to 
632 cells was blocked by the peptide aldehyde inhibitor 
LLnL (Figure 4~). Since LLnL and other peptide aldehydes 
also inhibit some classes of lysosomal protease (Sasaki 
et al, 1990) we also tested the analog LLM, which has a 
selectively reduced activity against the proteasome and, 
in contrast with LLnL, had no effect on presentation of 
ovalbumin introduced into the cytosol by electroporation 
(Rock et al., 1994). As shown in Figure 4c, LLM also had 
no effect on presentation of macropinocytosed ovalbum- 
in. Similarly, chloroquine, a pleiotropic inhibitor of acid 
pHdependent proteases did not inhibit ovalbumin presen- 
tation and in fact showed a reproducible stimulation, indi- 
cating that macropinosomal antigen processing is unnec- 
essary and might actually reduce the efficiency of class 
I MHC presentation of exogenous antigens (see Figure 
3d). Thus, cytosolic rather than macropinosomal pro- 
cessing of ovalbumin was necessary for class I presen- 
tation. 
Discussion 
Here, we demonstrate that macropinocytosed soluble an- 
tigen can gain access to the cytosol for presentation on 
class I MHC molecules. Presentation was regulated by the 
level of macropinocytic activity, utilized the conventional 
class I pathway and required no special antigen formula- 
tion. A pathway for the presentation of exogenous material 
on class I MHC molecules was predicted (Bevan, 1987; 
Townsend and Bodmer, 1989) based on reports of CD8 
T cell priming by soluble proteins (Wraith et al., 1987; 
Staerz et al., 1987) and cross-priming of host CD8 T cells 
to donor cell determinants restricted by MHC molecules 
found only on recipient bone marrow-derived cells (Fink 
et al., 1983; Gooding and Edwards, 1980). Such a pathway 
may also be necessary to explain how tumorderived solu- 
ble heat shock proteins elicit tumor-specific macrophage- 
dependent immunity (Udono et al., 1994) and how tumor 
cells induce CD8 responses restricted by the MHC of the 
host bone marrow rather than that of the inducing tumor 
cells (Huang et al., 1994). 
These in vivo observations suggest that there are excep 
tions to the general embargo on class I presentation of 
exogenous antigens. Usually, this blockade is considered 
necessary because cells that passively acquire CTL deter- 
minants, LJt are not themselves infected, would be killed 
by activated CTLs recognizing the exogenous material in 
the context of class I MHC molecules. However, it may 
be desirable to override this embargo to prime CTL under 
certain conditions. For example, professional APCs are 
BMM were grown as described (Racoosin and Swanson, 1989). detached from the plastic, and replated at 1.5 x 10’ cells/ml onto sterile 24 mm 
coverslips. Following pulsing with FlTC-dextran (5 mg/ml) for 10 min in the presence of 3000 U/ml MCSF the ceils were washed in PBS/BSA, 
then mounted in 0.4% trypan blue in HBSWBSA in a Dvorak-Stotler perfusion chamber for viewing in Biorad MRC 500 laser confocal microscope 
at 30°C-370C. 
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Table 1. Dimethyt Amiloride Inhibits Presentation During but Not 
Before or After an OVA Pulse 
Window of DMA exposure 
PMA None Pre8xposure &exposure Postexposure 
Percentage Lao2 +ve cells 
+ PMA 2.73 1.78 0.39 2.42 
- PMA 0.39 NT NT NT 
BMMs were stimulated with PMA 48 min prior to OVA pulsing. Dimethyl 
amiloride (DMA; 100 uM) was included in separate incubations during 
different 20 min periods and then removed. Exposure to DMA was 
either at the start of PMA stimulation (Preexposure), 10 min prior to 
and during the 10 min OVA pulse (Coexposure) or after removal of 
OVA (Postexposure). Following a 2 hr chase, cells were overlaid with 
832 cells and presentation was quantitated as described in Figure 3, 
legend and in Experimental Procedures. NT, not tested. 
required to initiate most CTL responses (Lafferty et al., 
1993; Schwartz, 1989; Ohashi et al., 1991; Chen et al., 
1992; Townsend and Allison., 1993) suggesting that a 
pathogen may evade an immune response by not infecting 
or replicating within professional APCs or within cell type8 
that traffic to lymphoid area8 (Kundig et al., 1995). In this 
ca88, the professional APC would not be able to use the 
conventional class I MHC pathway, which require8 infeC- 
tion of the APC and subsequent de novo synthesis of 
pathogen-encoded proteins. To initiate a CTL response 
against such a pathogen, the professional APC would be 
required to present exogenous material on its class I MHC 
molecules. 
What features should such a pathway for presentation 
of exogenous antigen on class I MHC molecules have? 
First, it should be mostly confined to professional APCs 
so that uninfected cells do not become targets for activated 
effector CD8 cells. Second, in contrast with the constitu- 
tive clathrin-mediated endocytic pathway, it should be up- 
regulatable to boost presentation of exogenous antigens 
in defined situations Third, the loading of class I MHC 
should be cell autonomous, in that only class I MHC mole- 
cules on the cell taking up antigen should be loaded to 
avoid passive transfer of material to bystander cells. 
Fourth, the conventional proteasome- and TAP-depend- 
ent class I MHC pathway should be involved to ensure 
that CTLs are induced to epitopes that will be recognized 
when endogenously synthesized material is processed 
and presented. In other words, T cells elicited by exoge- 
nous material must be useful as effector cells. 
All of these features are provided by the macropinocytic 
pathway described here. It is most active in professional 
APCs and can be up- and down-regulated (Swanson, 
1989; Sallusto et al., 1995). Importantly, we have shown 
that presentation of soluble antigen on class I MHC mole- 
cules was similarly modulated upwards or downwards de- 
pending on ruffling and macropinocytic activity. Although 
we have no direct evidence that presentation on class I 
MHC molecules occurs via this pathway in vivo, we sug- 
gest that it constitutes a likely route for CTL induction by 
exogenous antigen. 
In a series of studies, Rock and colleagues have charac- 
terized the ability of macrophages and macrophage cell 
PMA 
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Fix+ + + - - 
C d 
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LLM - - + - : 
FUA + + + - - - 
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Figure 4. Effects of Gelonin, Brefeldin A, LLnL, LLM, and Chloroquine 
on Presentation of Macropinocytosed Cvalbumin on Class I MHC Mol- 
ecules Assessed Using 832 Indicator Cells 
(a) BMM pulsed with ovalbumin in the presence or absence of gelonin. 
(b) BMM pulsed with ovalbumin and chased in the presence or absence 
of brefeldin A for 8 hr. 832 cells were overlaid on either fixed cells or 
live cells washed free of brefeldin A. Dvalbumin pulsing of BMM in 
the presence or absence of LLnL or LLM (c) or chloroquine (d). 
BMM were pretreated with PMA 45 min prior to ovalbumin pulsing. 
Times of addition of inhibitors prior to ovalbumin pulsing were the 
following: gelonin (1 PM), 20 min; LLnL or LLM (N-acetyl-L-leucinyl-L- 
leucinal-L-norleucinal and N-acetyl-L-leucinyl-L-leucinal-methional, 
respectively; both 50 uM) or chloroquine (100 PM), all at 80 min. Brefel- 
din A(5 uglml)was addedafterovalbumin pulsing and was replenished 
in the culture medium at 120 min intervals. Cells were chased for 6 
hr following ovalbumin pulsing and then overlaid with 832 cells either 
with (c, d, and where indicated in b) or without (a) prior fixation. Follow- 
ing an overnight incubation with 832 cells, T cell triggering was mea- 
sured as described and Figure 3 legend. Samples without drugs con- 
tained equivalent amounts of DMSO or ethanol carrier. 
line8 to present exogenous antigen coupled to latex beads 
(Kovacsovics-Bankowski et al., 1993; Kovacsovics- 
Bankowski and Rock, 1995). As in the studies reported 
here, this particulate antigen was also presented via the 
classical class I pathway, although it was not clear how 
antigen coupled to latex beads gained access to the cyto- 
sol. In a recent study, it was reported that coadministration 
of soluble antigen together with phagocytosable particles 
gave enhanced presentation compared with equivalent 
amounts of antigen conjugated to beads (Reis e Sousa 
and Germain, 1995). Again, presentation was via the con- 
ventional class I pathway, indicating phagosome to cytosol 
transfer. In contrast, using a preparation of latex bead- 
coupled antigen, a distinct brefeldin A-insensitive mecha- 
nism was described and was attributed to loading of 
mature post-Golgi class I MHC molecules either within 
phagocytic vacuoles or following regurgitation and recap- 
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ture of processed material (Harding and Song, 1994). The 
reasons for these discrepant results using synthetic partic- 
ulate antigens are not clear, but unconventional access 
to the conventional class I pathway as described here and 
in other recent studies (Kovacsovics-Bankowski and Rock, 
1995; Reis e Sousa and Germain, 1995) would seem a 
more appropriate strategy for the immune system to adopt. 
As discussed above, class I MHC loading following ex- 
tracellular or endosomal processing, although clearly 
demonstrated in several in vitro studies, might not provide 
the best match between class l-restricted determinants 
at the induction and effector phases of the response. More- 
over, the efficiency of post-Golgi loading of mature class 
I MHC might be dictated by the availability of empty class 
I molecules, reusable class I MHC molecules, or class I 
molecules targeted to the endocytic/phagocytic pathway 
by association with the invariant chain (Sugita and Bren- 
ner, 1995). In contrast, class I MHC availability would be 
ensured by regulating access of exogenous antigen to 
the conventional pathway. Processing in the inductive and 
effector phases of the response would be uniform and 
potentially damaging sensitization of bystander cells 
would be avoided. Interestingly, some bacteria stimulate 
macropinocytosis (Francis et al., 1993) resulting in non- 
phagocytic sequestration within macropinosomes (Al- 
puchearanda et al., 1994). This observation raises the 
possibility that organisms, which themselves have no obvi- 
ous means of entering the cytosol, but to which CD8 T 
cell responses can nonetheless be made, might transfer 
material through macropinosome membranes into the cy- 
tosol. Yersinia (Starnbach and Sevan, 1994) and Listeria 
monocytogenes mutants that lack listeriolysin (Szalay et 
al., 1994) constitute two possible examples. However, it 
should be stressed that several studies have demon- 
strated distinct nonclassical loading of class I MHC mole- 
cules, which is usually (Schirmbeck et al., 1995; Harding 
and Song, 1994) though not always (Liu et al., 1995; de 
Bruijn et al., 1995), brefeldin A insensitive. Strikingly, the 
antigen preparations used are mostly particulate, sug- 
gesting that the nature of the antigen may affect the path- 
way used. Thus, intracellular pathogens confined to vacu- 
oles may load class I molecules at these sites following 
processing by endosomal rather than proteasomal prote- 
ases (Pfeifer et al., 1993; de Bruijn et al., 1995). The key 
point is that a good match between epitopes inducing 
CTLs and those presented by other cell types needs to 
be made. Perhaps two distinct pathways for loading class 
I MHC molecules with extracellular antigens exist: one for 
pathogens confined to vacuoles and a second, described 
here, which may be most important for pathogen-derived 
class I determinants that are loaded via the conventional 
class I pathway. 
In summary, we have begun to define a pathway that 
allows unconventional access to the conventional class I 
MHC pathway in a regulatable and cell type-specific man- 
ner. It will be important to define the stimuli of macropino- 
cytosis, presumably acting through rat and related 
GTPases, that might operate in vivo. The mechanism de- 
scribed here may constitute an important arm of the nor- 
mal CD8 T cell response and may be useful for vaccination 
purposes. 
Experimental PWcedurea 
EGF was purchased from AMS Biotechnology (Witney, Oxon, En- 
gland). Cell culture media and 6418 were from GIBCO BRL (Paisley, 
Scotland). Lab-Tek tissue culture dishes (100 mm) were from Nunclon 
(Roskilde, Denmark) and all other tissue culture plastics were from 
Costar (Bucks, England). Brefeldin A and hygromycin B were pur- 
chased from Boehringer Mannheim (East Sussex, England). Fetal calf 
serum (FCS) was from Advanced Protein Products (West Bromwich, 
England). 5Bromo4 chloro-3-indolyf+-bgalactoside (X-Gal) was 
from Calbiochem-Novabiochem (Nottingham, England). Glass cover 
slips and slides were from BDH Chemicals Ltd. (Poole, England). All 
cell culture 
A431 cells (a gift from Dr. P. Smith, University College, London) were 
maintained in DMEM containing heat-denatured (FCS) (10%). kana- 
mycin (100 U/ml) and glutamine (2 PM). 832 cells were maintained 
in RPM1 1840, 10% FCS supplemented with sodium pyruvate (1 mM), 
nonessential amino acids (1 mM), glutamine (2 uhf), kanamycin (100 
U/ml), hygromycin B (409 U/ml), and geneticin (6418; 1 mglml). BMM 
were obtained from C57SUW female mice, and expanded in 30% L 
cell supernatant for 5-7 days as described by Racoosin and Swanson 
(1989). The macrophages were detached from dishes by washing 
briefly with ice-cold phosphate-buffered saline (PBS), incubation with 
IO ml PBS containing IO mM EDTA, 20% FCS at 37W for 10 min, 
and agitating vigorously with an automatic pipettor. For assays, BMM 
were cultured at 105.* x IO5 per well in 24well plates coated with 
poly-L-lysine or onto sterile 24 mm circular glass cover slips for micros- 
copy. Greater than 95% of the cells were macrophages as determined 
by immunofluoresence staining with a monoclonal antibody (Ml/ 
70.15.1, Serotec, Oxford, England) to the macrophage cell surface 
marker Mac-l. 
Uptake of Fluld Phase Markers 
Uptake of the fluid phase markers HRP and FlTCtonjugated dextran 
was detected by microscopy. Exposure to these solute markers was 
performed as previously described (West et al., 1989; Hewlett et al., 
1994, respectively). Prior to use the HRP and FITC-dextran solutions 
used were passed through a 0.22 pm filter. A431 cells were grown 
on 13 mm diameter glass cover slips, thickness number 2. Cells were 
incubated with HRP for 10 min, washed, then chased in culture me- 
dium in the absence of HRP for the times indicated before rinsing in 
PBS, exposure to 0.4% trypan blue in PBS for 2 min, and then fixation 
in 0.5% glutaraldehyde. HRP activity was developed with 0.5 mg/ml 
diaminobenzidine (DAB) and 0.01% hydrogen peroxide in PBS. 
BMM were grown on 24 mm cover slips and exposed to the solute 
marker FITC-dextran (5 mglml) in a similar manner, in the presence 
or absence of either 30 rig/ml PMA or 3009 U/ml M-CSF. Cover slips 
were mounted in a Dvorak-Stotler perfusion chamber in PBS, 0.4% 
trypan blue and viewed at 30°C-370C on a Nikon Microphot-SA 
attached to a confocal laser scanning microscope (MRC-800 series, 
Bio-Rad Laboratories, Cambridge, England). 
Fluid phase pinocytosis was quantitated by measuring the uptake 
of the solute marker FITC-dextran by fluorimetry, essentially as de- 
scribed by Racoosin and Swanson (1989). Quantitation of FITC-dex- 
tran uptake, after a 2 hr exposure, was performed by excitation at 488 
nm (2.5 nM bandpass) and measurement of emmision at 520 nm (2.5 
nM bandpass). 
Antigen Uptake and Presentation 
Presentation of ovalbumin 257-284 on Kb (Moore et al, 1988) was 
detected using the T cell hybridoma 832. which carries a 8-galac- 
tosidase construct driven by NF-AT elements from the IL-2 promoter 
(Sanderson and Shastri, 1994; Karttunnen et al., 1992). Cvalbumin 
(Lorne Labs, batches 3CtC57lN or 34M877) gave a background of T 
cell triggering upon incubation with fixed APCs of <O.l% activated 
832 cells. BMM, obtained as described above, were pulsed with IO 
mg/ml ovalbumin dissolved in serum-free DMEM for IO-30 min and 
fixed with 1% paraformafdehyde for 30 min. Excess fixative was 
quenched with 0.2 M glycine in PBS and the BMM were overlaid with 
B3Z cells overnight. The 832 cells were assayed for 6galactosidase 
production with X-Gal as described bysanderson et al. (1994). Activa- 
tion of the 832 cells was quantitated by counting the number of blue 
(LacZ-positive cells) on a Neubauer counting chamber and expressing 
the result as a percentage of the total number of cells present. In all 
cases a minimum of 103 cells were counted. 
For antigen presentation assays, BMMs in a 24well plate were 
pulsed with 250 ul prewarmed ovalbumin (10 mglml) in DMEM with 
or without 30 “g/ml PMA for a period of IO min. The cells were washed 
three times with PBS/BSA (1 mg/ml). Following loading, the cells were 
chased for 2 hr in complete DMEM before overlaying with 3.5 x Iv 
832 cells in complete RPM1 and incubating overnight. To remove the 
832 cells, the plates were spun at 400 rpm for 3 min and the majority 
of the medium then removed. Vigorous pippetting of the remainder 
of the medium removed the majority of 832 cells and incubation at 
room temperature in trypsin/EDTA dislodged the remainder. After 
washing twice, LacZ activity within the cells was developed as de- 
scribed above. 
Where indicated, the following inhibitors were included in the anti- 
gen presentation assays. Amiloride and DMA were stored as stock 
solutions of 0.6 M and 10 mM, respectively, in DMSO, at O*C, and 
diluted in culture media for use. Gelonin was used at a final concentra- 
tion of 1 pM after dilution, in culture medium, from a 20 uml stock 
solution, in DMSG. BMMs were incubated with amiloride and DMA and 
gelonin for 10 min and 20 min, respectively, prior to OVA pulsing and 
during the ovalbumin pulse. Brefeldin A was prepared at 5 mg/ml in 
DMSO and was used at 5 @ml in complete DMEM for 6 hr. As Brefel- 
din A has a short lifetime in culture, the medium containing it was 
replaced every 2 hr. Following a 6 hr chase, cells were either fixed 
with paraformaldehyde, as outlined above, or overlaid with 832 and 
incubated overnight as indicated. The peptide aldehydes LLnL and 
LLM (50 pM) and the lysosomotropic amine chloroquine (100 uM) were 
preincubated for the same period with BMM as PMA, and the cells 
were chased in the presence of these inhibitors for a further 6 hr before 
fixation. 
In all cases, control cultures were incubated in DMSCI at a concentra- 
tion equivalent to that in the inhibitor preparation. 
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